Dr. Martens (LON:DOCS) Trading Down 12.4% – Here’s Why

Dr. Martens plc (LON:DOCS) was down 12.4% during mid-day trading on Tuesday . The stock traded as low as GBX 65 and last traded at GBX 66.30. Approximately 4,229,807 shares traded hands during trading, an increase of 138% from the average daily volume of 1,776,838 shares. The stock had previously closed at GBX 75.65.

Analyst Ratings Changes

A number of research analysts recently weighed in on the company. Peel Hunt reiterated a “buy” rating on shares of Dr. Martens in a report on Thursday, November 20th. Berenberg Bank restated a “buy” rating on shares of Dr. Martens in a report on Tuesday. Two investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of GBX 6,000.

Dr. Martens Trading Up 3.6%

The firm has a market cap of £657.97 million, a price-to-earnings ratio of 40.04, a price-to-earnings-growth ratio of 6.40 and a beta of 0.11. The company has a quick ratio of 1.13, a current ratio of 2.85 and a debt-to-equity ratio of 127.27. The business has a 50 day moving average price of GBX 75.88 and a 200-day moving average price of GBX 83.26.

Dr. Martens (LON:DOCS) last released its quarterly earnings results on Thursday, November 20th. The company reported GBX (0.90) EPS for the quarter. Dr. Martens had a return on equity of 18.91% and a net margin of 7.89%. As a group, research analysts expect that Dr. Martens plc will post 2.5809394 EPS for the current fiscal year.

Insider Buying and Selling at Dr. Martens

In other Dr. Martens news, insider Robert Hanson bought 96,000 shares of the company’s stock in a transaction dated Friday, December 5th. The shares were acquired at an average cost of GBX 79 per share, with a total value of £75,840. Insiders bought 97,130 shares of company stock worth $7,673,816 in the last three months. 2.79% of the stock is owned by company insiders.

Dr. Martens Company Profile

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history. It operates in over
60 countries and employs over 3,650 people worldwide. Its operations are split across both Direct-to-Consumer and
wholesale channels, and in addition to its world-renowned “1460” boot its product segments span shoes including the
1461 shoe and Adrian loafer, sandals including the Zebzag mule, Kids ranges, as well as a growing line of bags and
accessories.

The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.